Google News • 12/23/2025 – 12/24/2025
Pfizer's stock has declined following the confirmation of a patient death in a hemophilia drug trial for Hympavzi. The incident has raised safety concerns regarding the drug. Various sources, including Yahoo Finance, Bloomberg, Reuters, and Fierce Pharma, reported on the situation.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.





